Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy. [PDF]
Endocrinol Metab (Seoul), 2023 Roh TH +5 more
europepmc +1 more source
Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate [PDF]
, 2020 Katarzyna Pelewicz +2 more
openalex +1 more source
A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Graves’ Hyperthyroidism and Graves’ Orbitopathy [PDF]
, 2018 Roberto Negro +4 more
openalex +1 more source
SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy [PDF]
, 2020 Alan C.H. Lee +3 more
openalex +1 more source
The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves’ orbitopathy [PDF]
, 2022 Ru‐Xuan Zhao +5 more
openalex +1 more source
Effects of pulse glucocorticoid treatment on retinal blood flow in patients with active Graves' orbitopathy. [PDF]
BMC OphthalmolMohammadi H, Güneş İB, Arı Ş.
europepmc +1 more source
Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves’ Orbitopathy [PDF]
, 2018 Piotr Miśkiewicz +4 more
openalex +1 more source
Role of SerpinA3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. [PDF]
Invest Ophthalmol Vis SciKim MS +6 more
europepmc +1 more source
A novel method for measuring outcome of orbital decompression in Graves’ orbitopathy
, 2015 L. Baldeschi
openalex +1 more source
Clinical Impact of Radiotherapy in Steroid-Refractory Graves' Orbitopathy. [PDF]
CureusEscobar Peralta E +3 more
europepmc +1 more source